Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02007434 · ClinicalTrials.gov registry record · Phase 3
Patient Experience Study of Deoxycholic Acid Injection
A Phase 3 study, sponsored by Kythera Biopharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 84
- Enrollment target
NCT02007434 is a Phase 3 study that has completed, run by Kythera Biopharmaceuticals. The registered enrollment target is 84 participants.
The verdict
NCT02007434, a Phase 3 study, has completed, sponsored by Kythera Biopharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 84 participants
- Enrollment target
Study Summary
The objectives of this study are to determine the safety of deoxycholic acid subcutaneous (SC) injections in the submental area and to evaluate the effects of four interventions, relative to placebo in the submental area, particularly with regard to assessment and management of pain, bruising, and swelling/edema.
Interventions
- DRUG Placebo
- DRUG Loratadine
- DRUG Deoxycholic Acid Injection
- OTHER Cold Compress
- DRUG Lidocaine / Epinephrine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2013-12 |
| Est. Completion | 2014-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02007434
The ClinicalTrials.gov registry entry for NCT02007434 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kythera Biopharmaceuticals, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Placebo is the first listed.
NCT02007434 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02007434 about?
NCT02007434 is a clinical study titled "Patient Experience Study of Deoxycholic Acid Injection". The objectives of this study are to determine the safety of deoxycholic acid subcutaneous (SC) injections in the submental area and to evaluate the effects of four interventions, relative to placebo in the submental area, particularly with regard to assessment and management of pain, bruising, and s...
What is the current status of trial NCT02007434?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 84 participants. The study started on 2013-12. Estimated completion is 2014-06.
What interventions are being tested in trial NCT02007434?
The interventions under investigation include: Placebo (DRUG), Loratadine (DRUG), Deoxycholic Acid Injection (DRUG), Cold Compress (OTHER), Lidocaine / Epinephrine (DRUG).
Who is sponsoring clinical trial NCT02007434?
This trial is sponsored by Kythera Biopharmaceuticals, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.